Bozena J Biernat, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 Redbird Cir, Suite 300, De Pere, WI 54115 Phone: 920-338-6870 |
Ronelle M Moe, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 555 Redbird Cir, Suite 300, De Pere, WI 54115 Phone: 920-338-6870 |
Robert Elwood Wampler, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3860 Monroe Rd, De Pere, WI 54115 Phone: 920-496-4700 Fax: 920-431-1950 |
Dr. Roderick L Meves, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 555 Redbird Cir, De Pere, WI 54115 Phone: 920-338-6870 |
Elaine Melissa Aquino, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1881 Chicago St, De Pere, WI 54115 Phone: 920-403-8000 |
David Gearhart Richards, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3860 Monroe Rd, De Pere, WI 54115 Phone: 920-496-4700 Fax: 920-431-1950 |
Kathryn A Lafond, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 Redbird Cir Ste 300, De Pere, WI 54115 Phone: 920-338-6870 Fax: 920-338-6829 |
Malena Dzwonkowski, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3860 Monroe Rd, De Pere, WI 54115 Phone: 920-496-4700 Fax: 920-431-1950 |
Dr. Saurabh Narad, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1881 Chicago St, De Pere, WI 54115 Phone: 920-403-8000 |
Triton J Krizenesky, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 Lawrence Dr, De Pere, WI 54115 Phone: 920-983-3220 Fax: 920-983-3226 |
News Archive
Today, the U.S. Food and Drug Administration approved Xuriden (uridine triacetate), the first FDA-approved treatment for patients with hereditary orotic aciduria. Hereditary orotic aciduria is a rare metabolic disorder, which has been reported in approximately 20 patients worldwide.
Diabetes in pregnant women can have serious health consequences for both mother and baby, and the U.S. Centers for Disease Control and Prevention has identified four target areas in which increased surveillance, screening, and preventive care can improve maternal and infant health.
C. R. Bard, Inc. today announced that it has reached a definitive agreement to acquire SenoRx, Inc. (Nasdaq: SENO), for a purchase price of $11.00 per share in cash, totaling approximately $200 million, net of cash acquired.
Both Asia and Africa are home to many plants that can be used for the treatment of many diseases and their medicinal properties are gaining interest in western societies.
The first award under BioCurate's new "Proof of Concept" fund has been granted to the Monash Biomedicine Discovery Institute.
› Verified 8 days ago